{"organizations": [], "uuid": "a38c7c105d2291a18f446535c43231a330e84dc1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-solid-biosciences-reports-full-yea/brief-solid-biosciences-reports-full-year-2017-financial-results-and-provides-corporate-update-idUSASC09U7K", "country": "US", "domain_rank": 408, "title": "BRIEF-Solid Biosciences Reports Full Year 2017 Financial Results And Provides Corporate Update", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-29T16:04:00.000+03:00", "replies_count": 0, "uuid": "a38c7c105d2291a18f446535c43231a330e84dc1"}, "author": "", "url": "https://www.reuters.com/article/brief-solid-biosciences-reports-full-yea/brief-solid-biosciences-reports-full-year-2017-financial-results-and-provides-corporate-update-idUSASC09U7K", "ord_in_thread": 0, "title": "BRIEF-Solid Biosciences Reports Full Year 2017 Financial Results And Provides Corporate Update", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-solid biosciences", "sentiment": "negative"}, {"name": "reuters staff    solid biosciences inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 29, 2018 / 1:06 PM / Updated 10 minutes ago BRIEF-Solid Biosciences Reports Full Year 2017 Financial Results And Provides Corporate Update Reuters Staff \n  Solid Biosciences Inc: \n* SOLID BIOSCIENCES REPORTS FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE \n* SOLID BIOSCIENCES -‍ EXPECTS CASH AT DEC 31, IPO PROCEEDS, TO FUND OPERATING EXPENSES & CAPEX UNTIL END OF 2019​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-29T16:04:00.000+03:00", "crawled": "2018-03-29T16:22:30.016+03:00", "highlightTitle": ""}